Potent small molecule inhibitors of spleen tyrosine kinase (Syk)

被引：74

作者：

Lai, JYQ ^{[1
]}

Cox, PJ ^{[1
]}

Patel, R ^{[1
]}

Sadiq, S ^{[1
]}

Aldous, DJ ^{[1
]}

Thurairatnam, S ^{[1
]}

Smith, K ^{[1
]}

Wheeler, D ^{[1
]}

Jagpal, S ^{[1
]}

Parveen, S ^{[1
]}

Fenton, G ^{[1
]}

Harrison, TKP ^{[1
]}

McCarthy, C ^{[1
]}

Bamborough, P ^{[1
]}

机构：

[1] Aventis Pharmaceut, Bridgewater, NJ 08807 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(03)00658-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of oxindoles demonstrating inhibition of the pbosphorylation of biotinylated substrates of Syk and IgE/FcepsilonRI triggered basophil cell degranulation has been identified. A study of the SAR around sulfonamide 31 (IC50=5 nM, EC50= 1400 nM) is discussed. The modest cellular activity representative of the sulfonamide series was overcome when the Polar surface Area was lowered to < 110 Angstrom(2), leading to the identification of amide 32 (IC50= 145 nM, EC50= 100 nM). (C) 2003 Published by Elsevier Ltd.

引用

页码：3111 / 3114

页数：4

共 50 条

[1] Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors
Singh, Rajinder
Masuda, Esteban S.
Payan, Donald G.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3614 - 3643
[2] Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents
Kaur, Charanjit
Thakur, Amandeep
Liou, Ke-Chi
Rao, Neralla Vijayakameswara
Nepali, Kunal
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (09) : 897 - 914
[3] Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.
Crackower, M. A.
Moy, L. Y.
Jia, Y.
Yu, H.
Vincent, S.
Miller, J. R.
Lieber, G.
Fernandez, X.
Caniga, M.
Gil, M.
Wilhelm, A.
Houshyar, H.
Northrup, A.
Chapman, R.
Abraham, W. M.
Kelly, N.
Hickey, E.
Miller, T.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB49 - AB49
[4] Spleen Tyrosine Kinase (Syk) Biology, Inhibitors and Therapeutic Applications
Singh, Rajinder
Masuda, Esteban S.
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 379 - 391
[5] Discovery and SAR of novel [1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK)
Cywin, CL
Zhao, BP
McNeil, DW
Hrapchak, M
Prokopowicz, AS
Goldberg, DR
Morwick, TM
Gao, A
Jakes, S
Kashem, M
Magolda, RL
Soll, RM
Player, MR
Bobko, MA
Rinker, J
DesJarlais, RL
Winters, MP
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) : 1415 - 1418
[6] Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases
Tang, Su'an
Yu, Qinghong
Ding, Changhai
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (03) : 291 - 303
[7] Atypical inactive-state inhibitors of spleen tyrosine kinase (SYK)
Altman, Michael
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[8] Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors
Cervi, Giovanni
D'Alessio, Roberto
Bindi, Simona
Buffa, Laura
Burocchi, Alessia
Canevari, Giulia
Modugno, Michele
Motto, Ilaria
Saturno, Grazia
Orsini, Paolo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 270
[9] Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)
Farmer, Luc J.
Bemis, Guy
Britt, Shawn D.
Cochran, John
Connors, Martin
Harrington, Edmund M.
Hoock, Thomas
Markland, William
Nanthakumar, Suganthini
Taslimi, Paul
Ter Haar, Ernst
Wang, Jian
Zhaveri, Darshana
Salituro, Francesco G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6231 - 6235
[10] Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders
Abdel-Magid, Ahmed F.
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (01): : 18 - 19

← 1 2 3 4 5 →